Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 2Thoracic 1Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Breast 1

Conditions

Breast Neoplasms 7Anemia 6Multiple Myeloma 2Lymphoma 2Small Cell Lung Carcinoma 1Red-Cell Aplasia, Pure 1Prostatic Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Lung Neoplasms 1Leukemia 1Fatigue 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Cyclophosphamide 3Pyridoxine 2Amifostine 2trastuzumab deruxtecan 1sodium thiosulfate 1sargramostim 1sacituzumab govitecan 1eribulin 1Triptorelin Pamoate 1Trastuzumab 1Thiotepa 1Social Determinants of Health 1Radiotherapy 1Pregabalin 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Methotrexate 1Furosemide 1Etoposide 1Epoetin Alfa 1Duloxetine Hydrochloride 1Drug Therapy 1Doxorubicin 1Dihydrouracil Dehydrogenase (NADP) 1Cisplatin 1Chemotherapy, Adjuvant 1Celecoxib 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Epoetin Alfa × Breast × Clear all
NCT00003600 2016-07-13

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
344 enrolled
BreastClassical hematologyLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cellThoracic

Anemia, Breast Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Precancerous Conditions, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡